Global Darbepoetin Alfa Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Published On: August 2018
 
Report ID:293868
 
 
Pages: 124




Darbepoetin alfa (INN) is a re-engineered form of erythropoietin containing 5 amino acid changes (N30, T32, V87, N88, T90) resulting in the creation of 2 new sites for N-linked carbohydrate addition. It has a 3-fold longer serum half-life compared to epoetin alpha and epoetin beta. It stimulates erythropoiesis (increases red blood cell levels) by the same mechanism as rHuEpo (binding and activating the Epo receptor) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy.

Scope of the Report:

This report focuses on the Darbepoetin Alfa in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The classification of Darbepoetin Alfa includes Epogen, Procrit, Aranesp and others, and the proportion of Epogen in 2017 is about 45%.

Darbepoetin Alfa is widely used for Patients with Chronic Kidney Disease, Patients with Cancer others. The most proportion of Darbepoetin Alfa is used for the Patients with Chronic Kidney Disease, and the proportion in 2017 is 62%.

North America is the largest consumption place, with a consumption market share nearly 47% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 41%.

The worldwide market for Darbepoetin Alfa is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Amgen 

Johnson & Johnson

Kyowa Hakko Kirin

Novartis

3SBio

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Epogen

Procrit

Aranesp

Others

Market Segment by Applications, can be divided into

Patients with Chronic Kidney Disease

Patients with Cancer

Others

There are 15 Chapters to deeply display the global Darbepoetin Alfa market.

Chapter 1, to describe Darbepoetin Alfa Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Darbepoetin Alfa, with sales, revenue, and price of Darbepoetin Alfa, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Darbepoetin Alfa, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Darbepoetin Alfa market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Darbepoetin Alfa sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview

1.1 Darbepoetin Alfa Introduction

1.2 Market Analysis by Type

1.2.1 Epogen

1.2.2 Procrit

1.2.3 Aranesp

1.2.4 Others

1.3 Market Analysis by Applications

1.3.1 Patients with Chronic Kidney Disease

1.3.2 Patients with Cancer

1.3.3 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Amgen 

2.1.1 Business Overview

2.1.2 Darbepoetin Alfa Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Amgen  Darbepoetin Alfa Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Johnson & Johnson

2.2.1 Business Overview

2.2.2 Darbepoetin Alfa Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Johnson & Johnson Darbepoetin Alfa Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Kyowa Hakko Kirin

2.3.1 Business Overview

2.3.2 Darbepoetin Alfa Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Kyowa Hakko Kirin Darbepoetin Alfa Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Novartis

2.4.1 Business Overview

2.4.2 Darbepoetin Alfa Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Novartis Darbepoetin Alfa Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 3SBio

2.5.1 Business Overview

2.5.2 Darbepoetin Alfa Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 3SBio Darbepoetin Alfa Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Darbepoetin Alfa Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Darbepoetin Alfa Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Darbepoetin Alfa Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Darbepoetin Alfa Manufacturer Market Share in 2017

3.3.2 Top 6 Darbepoetin Alfa Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Darbepoetin Alfa Market Analysis by Regions

4.1 Global Darbepoetin Alfa Sales, Revenue and Market Share by Regions

4.1.1 Global Darbepoetin Alfa Sales and Market Share by Regions (2013-2018)

4.1.2 Global Darbepoetin Alfa Revenue and Market Share by Regions (2013-2018)

4.2 North America Darbepoetin Alfa Sales and Growth Rate (2013-2018)

4.3 Europe Darbepoetin Alfa Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Darbepoetin Alfa Sales and Growth Rate (2013-2018)

4.5 South America Darbepoetin Alfa Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Darbepoetin Alfa Sales and Growth Rate (2013-2018)

5 North America Darbepoetin Alfa by Countries

5.1 North America Darbepoetin Alfa Sales, Revenue and Market Share by Countries

5.1.1 North America Darbepoetin Alfa Sales and Market Share by Countries (2013-2018)

5.1.2 North America Darbepoetin Alfa Revenue and Market Share by Countries (2013-2018)

5.2 United States Darbepoetin Alfa Sales and Growth Rate (2013-2018)

5.3 Canada Darbepoetin Alfa Sales and Growth Rate (2013-2018)

5.4 Mexico Darbepoetin Alfa Sales and Growth Rate (2013-2018)

6 Europe Darbepoetin Alfa by Countries

6.1 Europe Darbepoetin Alfa Sales, Revenue and Market Share by Countries

6.1.1 Europe Darbepoetin Alfa Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Darbepoetin Alfa Revenue and Market Share by Countries (2013-2018)

6.2 Germany Darbepoetin Alfa Sales and Growth Rate (2013-2018)

6.3 UK Darbepoetin Alfa Sales and Growth Rate (2013-2018)

6.4 France Darbepoetin Alfa Sales and Growth Rate (2013-2018)

6.5 Russia Darbepoetin Alfa Sales and Growth Rate (2013-2018)

6.6 Italy Darbepoetin Alfa Sales and Growth Rate (2013-2018)

7 Asia-Pacific Darbepoetin Alfa by Countries

7.1 Asia-Pacific Darbepoetin Alfa Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Darbepoetin Alfa Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Darbepoetin Alfa Revenue and Market Share by Countries (2013-2018)

7.2 China Darbepoetin Alfa Sales and Growth Rate (2013-2018)

7.3 Japan Darbepoetin Alfa Sales and Growth Rate (2013-2018)

7.4 Korea Darbepoetin Alfa Sales and Growth Rate (2013-2018)

7.5 India Darbepoetin Alfa Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Darbepoetin Alfa Sales and Growth Rate (2013-2018)

8 South America Darbepoetin Alfa by Countries

8.1 South America Darbepoetin Alfa Sales, Revenue and Market Share by Countries

8.1.1 South America Darbepoetin Alfa Sales and Market Share by Countries (2013-2018)

8.1.2 South America Darbepoetin Alfa Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Darbepoetin Alfa Sales and Growth Rate (2013-2018)

8.3 Argentina Darbepoetin Alfa Sales and Growth Rate (2013-2018)

8.4 Colombia Darbepoetin Alfa Sales and Growth Rate (2013-2018)

9 Middle East and Africa Darbepoetin Alfa by Countries

9.1 Middle East and Africa Darbepoetin Alfa Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Darbepoetin Alfa Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Darbepoetin Alfa Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Darbepoetin Alfa Sales and Growth Rate (2013-2018)

9.3 UAE Darbepoetin Alfa Sales and Growth Rate (2013-2018)

9.4 Egypt Darbepoetin Alfa Sales and Growth Rate (2013-2018)

9.5 Nigeria Darbepoetin Alfa Sales and Growth Rate (2013-2018)

9.6 South Africa Darbepoetin Alfa Sales and Growth Rate (2013-2018)

10 Global Darbepoetin Alfa Market Segment by Type

10.1 Global Darbepoetin Alfa Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Darbepoetin Alfa Sales and Market Share by Type (2013-2018)

10.1.2 Global Darbepoetin Alfa Revenue and Market Share by Type (2013-2018)

10.2 Epogen Sales Growth and Price

10.2.1 Global Epogen Sales Growth (2013-2018)

10.2.2 Global Epogen Price (2013-2018)

10.3 Procrit Sales Growth and Price

10.3.1 Global Procrit Sales Growth (2013-2018)

10.3.2 Global Procrit Price (2013-2018)

10.4 Aranesp Sales Growth and Price

10.4.1 Global Aranesp Sales Growth (2013-2018)

10.4.2 Global Aranesp Price (2013-2018)

10.5 Others Sales Growth and Price

10.5.1 Global Others Sales Growth (2013-2018)

10.5.2 Global Others Price (2013-2018)

11 Global Darbepoetin Alfa Market Segment by Application

11.1 Global Darbepoetin Alfa Sales Market Share by Application (2013-2018)

11.2 Patients with Chronic Kidney Disease Sales Growth (2013-2018)

11.3 Patients with Cancer Sales Growth (2013-2018)

11.4 Others Sales Growth (2013-2018)

12 Darbepoetin Alfa Market Forecast (2018-2023)

12.1 Global Darbepoetin Alfa Sales, Revenue and Growth Rate (2018-2023)

12.2 Darbepoetin Alfa Market Forecast by Regions (2018-2023)

12.2.1 North America Darbepoetin Alfa Market Forecast (2018-2023)

12.2.2 Europe Darbepoetin Alfa Market Forecast (2018-2023)

12.2.3 Asia-Pacific Darbepoetin Alfa Market Forecast (2018-2023)

12.2.4 South America Darbepoetin Alfa Market Forecast (2018-2023)

12.2.5 Middle East and Africa Darbepoetin Alfa Market Forecast (2018-2023)

12.3 Darbepoetin Alfa Market Forecast by Type (2018-2023)

12.3.1 Global Darbepoetin Alfa Sales Forecast by Type (2018-2023)

12.3.2 Global Darbepoetin Alfa Market Share Forecast by Type (2018-2023)

12.4 Darbepoetin Alfa Market Forecast by Application (2018-2023)

12.4.1 Global Darbepoetin Alfa Sales Forecast by Application (2018-2023)

12.4.2 Global Darbepoetin Alfa Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source




Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
   Our Clients
  • \
   Payment Mode



For More Information

   For More Information

If you have any query? Please contact us

sales@fiormarkets.com
+1-201-465-4211


Copyright © 2020 Fior Market Research LLP, All Rights Reserved.